Genotyping Assay Market Surges to USD 37.1 Billion by 2029: Thermo Fisher and Illumina at the Forefront | MarketsandMarkets™.

CHICAGO, June 19, 2024 /PRNewswire/ — The genotyping assay market is poised for substantial growth, projected to rise from USD 19.4 Billion in 2024 to USD 37.1 Billion by 2029, at a CAGR of 13.8%. Key drivers include advancements in technology, declining costs of DNA sequencing, and…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.